Uniform Suspension of the Clustered Triamcinolone Acetonide Particle
Purpose. MaQaid (MaQ) is a new triamcinolone acetonide commercialised in Japan to visualize the vitreous. Because MaQ is preservative-free, it has a lower risk of ocular toxicities. However, since MaQ is only available as a powder, it needs suspenssion. Suspension does not always result uniformally,...
Saved in:
| Main Authors: | Masahiko Sugimoto, Mineo Kondo, Masayuki Horiguchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2013/315658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of intralesional triamcinolone acetonide injections in the treatment of ostium granulomas following endoscopic dacryocystorhinostomy
by: ZHAI Ning, et al.
Published: (2025-06-01) -
Efficacy of different routes of triamcinolone acetonide administration on macular edema: A systematic review and network meta-analysis.
by: Kexin Liu, et al.
Published: (2025-01-01) -
Comparison of the In-Vitro Effects of Bevacizumab, Mitomycin-C, 5-Fluorouracil, and Triamcinolone Acetonide on the Viability of Cultured Human Tenon’s Fibroblasts
by: Pius Jonas Ocampo, MD, et al.
Published: (2014-12-01) -
Efficacy of combined topical nepafenac 0.3% with suprachoroidal injection of triamcinolone acetonide using a modified custom needle in pseudopkakic cystoid macular edema
by: Amin E. Nawar
Published: (2025-07-01) -
Optimization of Mucoadhesive Film Reinforced with Functionalized Nanostructured Lipid Carriers (NLCs) for Enhanced Triamcinolone Acetonide Delivery via Buccal Administration: A Box–Behnken Design Approach
by: Patteera Sodata, et al.
Published: (2025-02-01)